| Literature DB >> 33336406 |
Rafael de Albuquerque1, Elina Komsi1, Inna Starskaia1, Ubaid Ullah1, Riitta Lahesmaa1.
Abstract
Interleukin-32 (IL-32) is a pro-inflammatory cytokine that induces other cytokines involved in inflammation, including tumour necrosis factor (TNF)-α, IL-6 and IL-1β. Recent evidence suggests that IL-32 has a crucial role in host defence against pathogens, as well as in the pathogenesis of chronic inflammation. Abnormal IL-32 expression has been linked to several autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel diseases, and a recent study suggested the importance of IL-32 in the pathogenesis of type 1 diabetes. However, despite accumulating evidence, many molecular characteristics of this cytokine, including the secretory route and the receptor for IL-32, remain largely unknown. In addition, the IL-32 gene is found in higher mammals but not in rodents. In this review, we outline the current knowledge of IL-32 biological functions, properties, and its role in autoimmune diseases. We particularly highlight the role of IL-32 in rheumatoid arthritis and type 1 diabetes.Entities:
Keywords: Interleukin-32; rheumatoid arthritis; type 1 diabetes
Mesh:
Substances:
Year: 2021 PMID: 33336406 DOI: 10.1111/sji.13012
Source DB: PubMed Journal: Scand J Immunol ISSN: 0300-9475 Impact factor: 3.487